RCS - Agronomics Limited - Agronomics Capital Markets Day 3rd November

AgronomicsAnnouncement

21/09/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220921:nRSU0382Aa&default-theme=true

RNS Number : 0382A  Agronomics Limited  21 September 2022

21(st) September 2022

Agronomics Limited (https://agronomics.im/)

("Agronomics" or the "Company")

 

Agronomics Capital Markets Day Thursday 3(rd) November

 

Agronomics (AIM:ANIC), the leading listed company focused on the field of
cellular agriculture, is pleased to announce it will be hosting a capital
markets webinar to update and introduce investors, analysts and media to
cellular agriculture and a selection of leading companies in the portfolio
covering cell culture and precision fermentation technologies. The event will
take place online on Thursday 3(rd) November between 2pm - 4:30pm, and will
feature talks from the following speakers:

 

-     Anthony Chow, Co-Founder of Agronomics

-     Maija Itkonen, Co-Founder & CEO of Onego Bio

-     Jan Pacas, Founder & CEO of All G Foods

-     Mark Warner, Co-Founder & CEO of Liberation Labs

-     Krijn de Nood, Co-Founder & CEO of Meatable

-     Lou Cooperhouse, Co-Founder & CEO of BlueNalu

-     Ingvar Helgason, Co-Founder & CEO of VitroLabs

 

For registration and further details on the event, please use the following
link:

https://events.masterinvestor.co.uk/events/agronomics-capital-markets-day/
(https://events.masterinvestor.co.uk/events/agronomics-capital-markets-day/)

 

About Agronomics
(https://www.google.com/url?q=https://www.google.com/url?q%3Dhttps://agronomics.im/%26amp;sa%3DD%26amp;source%3Deditors%26amp;ust%3D1657614230868787%26amp;usg%3DAOvVaw3mASLRb5PoGSVFyynPDE3Q&sa=D&source=docs&ust=1657614230897307&usg=AOvVaw2gC6cdzFMtEF7FxFWoYEHt)

Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of 24 companies at the Pre-Seed to Series C stage in this rapidly
advancing sector. It seeks to secure minority stakes in companies owning
technologies with defensible intellectual property that offer new ways of
producing food and materials with a focus on products historically derived
from animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well as
addressing food security, human health, animal welfare and environmental
damage. This disruption will decouple supply chains from the environment and
animals, as well as being fundamental to feeding the world's expanding
population. A full list of Agronomics' portfolio companies is available
at https://agronomics.im/
(https://www.google.com/url?q=https://www.google.com/url?q%3Dhttps://clicktime.symantec.com/368cVqxx3R6vTFuHpf6MSE66Gi?u%253Dhttps%25253A%25252F%25252Fagronomics.im%25252F%26amp;sa%3DD%26amp;source%3Deditors%26amp;ust%3D1657614230869430%26amp;usg%3DAOvVaw0JVrLmcU8-NBpfa7VILSgF&sa=D&source=docs&ust=1657614230897432&usg=AOvVaw25knMFCSK3TfHJGV6BgRFB)
.

 

About Onego Bio Ltd (http://www.onego.bio)

Onego Bio Ltd is a game-changing biotech company producing animal-free egg
proteins with precision fermentation. When implemented in full scale, this new
production method provides significant benefits to the environment, food
security, as well as animal welfare. The team believes the chosen technology
is superior because of its efficiency and productivity. Based on the
anticipatory LCA published in Nature Food
(https://www.nature.com/articles/s43016-021-00418-2) , the technology shows
potential to significantly reduce most agriculture-associated impacts, such as
global warming and land use.

 

Egg is one of the world's most used animal proteins and difficult to replace
with alternative ingredients. Onego Bio will make it possible to manufacture
the same delicious foods entirely animal-free. Company aims to launch its
first product Bioalbumen™ as a food ingredient for food industry and later
enter the consumer market with its own branded products for baking and
cooking. Bioalbumen provides the nutritional and functional upsides of egg
white, without the environmental, ethical and safety-related concerns.

 

Founded in 2022 by Maija Itkonen (CEO), Christopher Landowski (CTO) and Jussi
Joensuu (COO), Onego Bio is a VTT spin-off that salutes the remarkable work
done by VTT Technical Research Centre of Finland for the next level cell ag
products and applications. Onego Bio's mission is to rethink eggs and give
people access to sustainable, delicious and healthy animal-free food. Learn
more at www.onego.bio (http://www.onego.bio/) and follow our journey in
LinkedIn (https://www.linkedin.com/company/onego-bio/) , Twitter
(https://twitter.com/onego_bio) and Instagram
(https://www.instagram.com/onego_bio/) .

 

About All G Foods (https://allgfoods.com/)

All G Foods know that proteins created through animal agriculture can't feed
the next generations of humans. The team's mission is to design a sustainable
food future - one that is limitlessly good. All G Foods believe the solution
to the growing protein demand is innovative, affordable, delicious,
nutritious, and sustainable alternative proteins, and are leading
technological innovations for the creation of next generation dairy and meat.
All G Foods are a trajectory to develop the world's first-to-market identical
dairy milk, entirely animal free through precision fermentation and are doing
plant-based meat differently to any other brand with their Love BUDS™
products.

 

About Liberation Labs (https://liberationlabsltd.com/)

Liberation Labs was formed to address the growing fermentation capacity gap
in cellular agriculture by providing the industry with the infrastructure to
commercialise novel protein manufacturing at the scale and cost structure
required by the market. Specifically, Liberation Labs is developing a global
network of fit-for-purpose precision fermentation facilities located in the
geographies that will drive market access for novel protein companies to
commercially succeed, enabling them to achieve price parity with animal
proteins. Founded by industry leaders with decades of experience in deployment
of precision fermentation facilities and commercial expertise in fermentation
market dynamics, our vision is to enable the technology that frees the world
from the costs of industrialised agriculture.

 

About Meatable (https://meatable.com/)

Meatable
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.meatable.com%2F&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=7ueVEPHCtd8qks8ISi6ixUE25DCWhB8dd7R58rVa1RU%3D&reserved=0)
 is an innovative, Dutch food company, aiming to deliver, at scale, the new
natural
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DWHrorhYqcKg&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=H32ZhMaO7q9MRDKEBZ%2FMgda%2BbOt7lyQev5HKKxW8ltc%3D&reserved=0)
, cultivated meat that looks like, tastes like, and has the nutritional
profile of traditional meat. Its proprietary opti-ox™ technology enables
Meatable to produce meat rapidly, sustainably, and without harming animals.
Founded in 2018 by Krijn de Nood (CEO), Daan Luining (CTO), and Dr. Mark
Kotter (principal inventor of opti-ox™technology), Meatable has brought
together a team of experts with unique knowledge in fields including molecular
biology, chemistry, tissue engineering, bioprocess development, food safety,
and food science to create the new natural meat.

Follow Meatable
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.meatable.com%2F&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=7ueVEPHCtd8qks8ISi6ixUE25DCWhB8dd7R58rVa1RU%3D&reserved=0)
: LinkedIn
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fitsmeatable%2F&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=v3Eiw1vv8tFKh6s3QBYH9y%2BDwHtE0cSLiR0mb1W20OU%3D&reserved=0)
,Twitter
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2Fitsmeatable&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=fj6XNDoP8%2BPKL06GlZ2sdaXCwN1%2FJtk4VhAK8SMre90%3D&reserved=0)
, Instagram
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.instagram.com%2Fitsmeatable%2F&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=WirfOL%2F5P%2BACusULQkjfp8w5jQubB0%2FcIHp%2B7uGMig4%3D&reserved=0)
, Facebook
(https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.facebook.com%2FmeetMeatable%2F&data=05%7C01%7CLaura%40agronomics.im%7C908d30620a3b42c9cefb08da664f8318%7C859da425033e4dd184c9c55a63f8b18d%7C1%7C0%7C637934788934372745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=tqGwGBMeczoBKOTfSerc7psiH3NnqCDlicU6wzGwNRM%3D&reserved=0)
.

 

About BlueNalu  (http://www.BlueNalu.com)   (http://www.BlueNalu.com)

BlueNalu's mission is to develop great-tasting, healthy, safe and trusted
cell-cultured seafood products that support the sustainability and diversity
of our ocean. The company has developed a robust pipeline of seafood products
from a wide array of species and plans to launch its first commercial product,
premium bluefin tuna toro, following regulatory approval. BlueNalu is a member
of the United Nations Global Compact and aligned with the UN Sustainable
Development Goals, a blueprint to achieve a better and more resilient future
for our planet. BlueNalu began its operations in 2018 and is based in San
Diego, California. To learn more about BlueNalu, please visit www.BlueNalu.com
(http://www.bluenalu.com/)

 

About VitroLabs (http://www.vitrolabsinc.com)

VitroLabs, founded in 2016 and headquartered in Milpitas California, is a
biotech company developing a scalable tissue engineering platform for the
efficient and environmentally friendly production of leather from only a few
cells.  Combining advanced tissue engineering processes with proprietary
advances to achieve commercial scale, VitroLabs is on a mission to produce
cell cultivated leather that achieves the look, feel and performance of
traditional leather without compromise. The cultivated leather process
involves taking a one-time collection of cells from an animal, which then
grows in a nutrient-rich environment. Without ever going back to the animal
again, the cells grow, divide, and form into tissue. The composition of the
material achieves the complexity of traditional hides, containing a variety of
proteins that make up a durable and luxurious material when finished, but
without the need to go to animals as an ongoing source of hides. The process
is more environmentally sustainable and favorable for animal welfare than that
which is used to produce traditional leather. For more information,
visit www.vitrolabsinc.com (http://www.vitrolabsinc.com/) .

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter, or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food
Institute's estimate that a US $1.8 trillion investment will be required in
order to produce just 10% of the world's protein using this technology, means
that we are on the cusp of a multi-decade flow of capital to build out
manufacturing facilities. Funding in the field of cellular agriculture is
accelerating, however still less than US$ 4 billion has been invested
worldwide since the industry's inception in 2016.

 

For further information please contact:

 

 Agronomics Limited                               Beaumont Cornish Limited  Canaccord Genuity Limited        Cenkos  Securities Plc   Peterhouse Capital Limited  TB Cardew
 The Company                                      Nomad                     Joint Broker                     Joint Broker             Joint Broker                Public Relations
 Richard Reed                                     Roland Cornish            Andrew Potts                     Giles Balleny            Lucy Williams               Ed Orlebar

 Denham Eke                                       James Biddle              Harry Rees                       Max Gould                Charles Goodfellow          Alistair Walker

                                                                            Alex Aylen (Head of Equities)    Michael Johnson
 +44 (0) 1624 639396                              +44 (0) 207 628 3396      +44 (0) 207 523 8000             +44 (0) 207 397 8900     +44 (0) 207 469 0936        +44 (0) 20 7930 0777

 info@agronomics.im (mailto:info@agronomics.im)                                                                                                                   +44 (0) 7738 724 630

                                                                                                                                                                  agronomics@tbcardew.com (mailto:agronomics@tbcardew.com)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUROVRUSUKUAR